MedPath

L.V. Prasad Eye Institute

L.V. Prasad Eye Institute logo
🇮🇳India
Ownership
Private
Established
1986-10-17
Employees
501
Market Cap
-
Website
http://www.lvpei.org

Clinical Trials

13

Active:0
Completed:5

Trial Phases

5 Phases

Early Phase 1:1
Phase 1:2
Phase 2:2
+2 more phases

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (12 trials with phase data)• Click on a phase to view related trials

Not Applicable
6 (50.0%)
Phase 1
2 (16.7%)
Phase 2
2 (16.7%)
Early Phase 1
1 (8.3%)
Phase 4
1 (8.3%)

Six-months Versus Nine-months ATT for Ocular TB

Phase 4
Completed
Conditions
Tuberculosis (TB)
Uveitis
Retinal Vasculitis
Choroiditis
Interventions
Drug: Anti-Tuberculosis Treatment
First Posted Date
2024-09-26
Last Posted Date
2024-09-26
Lead Sponsor
L.V. Prasad Eye Institute
Target Recruit Count
58
Registration Number
NCT06613919
Locations
🇮🇳

LV Prasad Eye Institute, Bhubaneswar, Odisha, India

🇲🇲

University of Medicine Magway, EENT Hospital, Nay Pyi Taw, Myanmar

🇹🇭

Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

To Evaluate the Clinical Safety and Efficacy of Limbal Stem Cell for Treatment of Superficial Corneal Pathologies".

Early Phase 1
Conditions
Corneal Scars and Opacities
First Posted Date
2021-06-21
Last Posted Date
2021-06-21
Lead Sponsor
L.V. Prasad Eye Institute
Target Recruit Count
20
Registration Number
NCT04932629

CHED - Congenital Hereditary Endothelial Dystrophy: New Paradigm Shift in Therapy Using Topical Eye Drops

Phase 2
Conditions
Congenital Hereditary Endothelial Dystrophy of Cornea
Interventions
Drug: Refresh Tears 0.5% Lubricant Eye Drops
First Posted Date
2021-04-14
Last Posted Date
2021-04-14
Lead Sponsor
L.V. Prasad Eye Institute
Target Recruit Count
30
Registration Number
NCT04843839
Locations
🇮🇳

L V Prasad Eye Institute, Hyderabad, Banjara Hills, India

SEED-LVPEI Myopia Study

Not Applicable
Conditions
Myopia
First Posted Date
2020-11-06
Last Posted Date
2021-09-24
Lead Sponsor
L.V. Prasad Eye Institute
Target Recruit Count
108
Registration Number
NCT04618510
Locations
🇮🇳

Pavan K. Verkicharla, Hyderabad, Telangana, India

Comparison of Different Fluence Settings for Yellow Subthreshold Laser Treatment in Diabetic Macular Edema

Completed
Conditions
Diabetic Retinopathy
First Posted Date
2018-06-27
Last Posted Date
2018-06-27
Lead Sponsor
L.V. Prasad Eye Institute
Target Recruit Count
32
Registration Number
NCT03571659
  • Prev
  • 1
  • 2
  • 3
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.